Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs

Estimating the posterior probability that genome-wide association findings are true or false

(2009) József Bukszár et al.   BIOINFORMATICS

Tardive dyskinesia and new antipsychotics

(2009) Christoph U Correll et al.   CURRENT OPINION IN PSYCHIATRY

Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis

(2009) Anna C Need et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects

(2009) Hélène Choquet et al.   HUMAN MOLECULAR GENETICS

Managing Weight Gain and Metabolic Issues in Patients Treated With Atypical Antipsychotics

(2009) David C. Henderson   JOURNAL OF CLINICAL PSYCHIATRY

Association Between HTR2C and HTR2A Polymorphisms and Metabolic Abnormalities in Patients Treated With Olanzapine or Clozapine

(2009) Arzu Gunes et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Genome-Wide Association Scan Meta-Analysis Identifies Three Loci Influencing Adiposity and Fat Distribution

(2009) Cecilia M. Lindgren et al.   PLoS Genetics

Genome-wide Association Study Identifies Genes for Biomarkers of Cardiovascular Disease: Serum Urate and Dyslipidemia

(2008) Chris Wallace et al.   AMERICAN JOURNAL OF HUMAN GENETICS

A searchable database of genetic evidence for psychiatric disorders

(2008) Thomas Konneker et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Genome-Wide Pharmacogenomic Analysis of the Response to Interferon Beta Therapy in Multiple Sclerosis

(2008) Esther Byun et al.   ARCHIVES OF NEUROLOGY

LDL-cholesterol concentrations: a genome-wide association study

(2008) Manjinder S Sandhu et al.   LANCET

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

(2008) Stefan Leucht et al.   LANCET

Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?

(2008) S Le Hellard et al.   MOLECULAR PSYCHIATRY

Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study

(2008) C Lavedan et al.   MOLECULAR PSYCHIATRY

Genomewide association for schizophrenia in the CATIE study: results of stage 1

(2008) P F Sullivan et al.   MOLECULAR PSYCHIATRY

Newly identified loci that influence lipid concentrations and risk of coronary artery disease

(2008) Cristen J Willer et al.   NATURE GENETICS

Variants in MTNR1B influence fasting glucose levels

(2008) Inga Prokopenko et al.   NATURE GENETICS

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation

(2008) Cristen J Willer et al.   NATURE GENETICS

SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Disruption of the RII subunit of PKA reverses the obesity syndrome of agouti lethal yellow mice

(2008) T. A. Czyzyk et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1

(2008) Jonathan M. Meyer et al.   SCHIZOPHRENIA RESEARCH

A systematic method for estimating individual responses to treatment with antipsychotics in CATIE

(2008) Edwin J.C.G. van den Oord et al.   SCHIZOPHRENIA RESEARCH

Genetic Mapping in Human Disease

(2008) D. Altshuler et al.   SCIENCE

Mapping the Genetic Architecture of Gene Expression in Human Liver

(2008) Eric E Schadt et al.   PLOS BIOLOGY